Picture of OPKO Health logo

OPK — OPKO Health News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapTurnaround

Opko Health Inc Expected To Post A Loss Of 8 Cents A Share: Earnings Preview

OPKO Health Inc <OPK.OQ> expected to post a loss of 8 cents a share - Earnings Preview 
  • OPKO Health Inc OPK.OQ OPK.O is expected to show a fall in quarterly revenue when it reports results on July 27 for the period ending June 30 2026

  • The Miami Florida-based company is expected to report a 16.3% decrease in revenue to $131.233 million from $156.81 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.The company's guidance on April 28 2026, for the period ended June 30, was for revenue between $127.00 million and $132.00 million.

  • ​LSEG's mean analyst estimate for OPKO Health Inc is for a loss of 8 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for OPKO Health Inc is $3.00, about 156.4% above its last closing price of $1.17

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Mar. 31 2026

-0.06

-0.07

-0.07

Met

0

Dec. 31 2026

-0.07

-0.07

-0.04

Beat

41.7

Sep. 30 2025

-0.04

-0.04

0.03

Beat

166.7​

Jun. 30 2025

-0.10

-0.11

-0.19

Missed

-67.7

​​Mar. 31 2025

-0.06

-0.07

-0.10

Missed

-45.8

Dec. 31 2024

-0.10

-0.09

0.01

Beat

110.7​

Sep. 30 2024

-0.09

-0.09

-0.09

Met

3.6

Jun. 30 2024

-0.11

-0.09

-0.01

Beat

89.5

This summary was machine generated July 24 at 21:39 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on OPKO Health

See all news